As a key inflammatory factor, IL-1 plays a critical role in autoimmune inflammatory diseases [62], and recent studies have confirmed that IL-1 receptor antagonist has successfully relieved the pain and frequent urination symptoms of IC/BPS patients (13/17) [63]. This evidence concerns the gene IL1B and Bartsocas-Papas syndrome 1.